-
Product Insights
NewQuarterly Wet Cooking Sauces pricing trends in the United States
Empower your strategies with our Quarterly Wet Cooking Sauces pricing trends in the United States report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Thematic Analysis
NewNext-Generation Chips – Thematic Intelligence
Reasons to buy the ‘Next-Generation Chips’ thematic intelligence report: Get a comprehensive overview of the next-generation chips theme and its impact on the semiconductor supply chain. Gain valuable insights into the semiconductor value chain as well as identify four trend-setting companies. Analyze the top three tech trends impacting next-generation chips: AI accelerators, neural networks, and chiplet architectures. Evaluate the key challenges in the chip manufacturing industry, including high demand, market monopoly, energy consumption, skills shortage, and tech nationalism. Interpret the...
-
Product Insights
NewCarcinoid Tumor – Drugs In Development, 2024
Empower your strategies with our Carcinoid Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Carcinoid tumors are slow-growing tumors arising from neuroendocrine cells and capable of secreting a variety of peptides and neuroamines. The common primary sites are the gastrointestinal (GI) tract, tracheobronchial tree, ovaries, and kidneys. The most common location of carcinoids is the small intestine. The term carcinoid is usually used for well-differentiated and low- to intermediate-grade neuroendocrine tumors. The Carcinoid Tumor drugs in...
-
Product Insights
NewChemotherapy Induced Anemia – Drugs In Development, 2024
Empower your strategies with our Chemotherapy Induced Anemia – Drugs In Development, 2024 report and make more profitable business decisions. Chemotherapy-induced anemia is a very common side effect of cancer treatment. Symptoms include severe fatigue, weakness, anxiety, lack of energy, shortness of breath, headaches, pale appearance, rapid heart rate or palpitations, chest pain, dizziness, cognitive impairment, loss of sexual desire, inability to perform daily functions, and/or depression associated with anemia. The predisposing factors include age, co-morbidities, and the time course of...
-
Product Insights
NewAnemia in Chronic Kidney Disease (Renal Anemia) – Drugs In Development, 2024
Empower your strategies with our Anemia in Chronic Kidney Disease (Renal Anemia) – Drugs In Development, 2024 report and make more profitable business decisions. Renal anemia is a disease in which the patient has an unusually low count of red blood cells associated with kidney disease. This type of anemia is caused by a lack of erythropoietin, a protein produced in the kidneys that helps to create red blood cells. Symptoms caused by renal anemia include pale skin and gums, shortness...
-
Product Insights
NewNeuroendocrine Tumors – Drugs In Development, 2024
Empower your strategies with our Neuroendocrine Tumors – Drugs In Development, 2024 report and make more profitable business decisions. Neuroendocrine tumor begins in the hormone-producing cells of the body’s neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cells. Symptoms include hyperglycemia, diarrhea, loss of appetite/weight loss, thickening or lump in any part of the body, jaundice, headache, anxiety, and gastric ulcer disease. Treatments include surgery, radiation therapy, and...
-
Product Insights
NewPulmonary Hypertension – Drugs In Development, 2024
Empower your strategies with our Pulmonary Hypertension – Drugs In Development, 2024 report and make more profitable business decisions. Pulmonary hypertension (PH) is a rare condition marked by high blood pressure in the pulmonary arteries, which supply blood to the lungs. It can stem from various causes, including heart or lung diseases. PH leads to arterial narrowing, forcing the heart to work harder, potentially resulting in heart failure. Common symptoms include breathlessness, fatigue, chest pain, and dizziness. Management involves medication, oxygen...
-
Product Insights
NewNeuroendocrine Cancer – Drugs In Development, 2024
Empower your strategies with our Neuroendocrine Cancer – Drugs In Development, 2024 report and make more profitable business decisions. A neuroendocrine cancer, often referred as a neuroendocrine tumor (NET) or neuroendocrine neoplasm, begins in the specialized cells of the body’s neuroendocrine system. These cells have traits of both hormone-producing endocrine cells and nerve cells. They are found throughout the body’s organs and help control many of the body’s functions. Hormones are chemical substances that are carried through the bloodstream to have...
-
Thematic Analysis
Wearable Tech in Medical Devices – Thematic Intelligence
Wearable Tech in Medical Devices Report Overview The wearable tech in medical devices industry is anticipated to witness remarkable growth over the next three years. Healthcare, particularly patient monitoring, remote training and support, and telehealth services, holds significant promise. Creating devices that can be used for longer, are lightweight, and have practical use cases will help companies generate demand and revenue. Additionally, the integration of artificial intelligence (AI) could usher in a new era of interactive and intelligent wearable devices,...